How to prepare for Policy 0070: Challenges and opportunities for clinical data publication in the EU

Published on: Jun 28, 2023

Policy 0070 is a ground-breaking initiative and the European Medicines Agency (EMA) represents the first agency on a global level that will grant access to clinical trial data on such a large scale. With the requirements for all non-Covid products expected to restart in 2023, there is preparation required for qualifying submissions – which include new marketing authorization applications (MAAs) and clinical variations.


Get Exclusive PDF Access

Return to Insights Center

Related Insights

Video

Oncology experts roundtable: Practical insights on FDA draft guidance discussing OS data in cancer trials

Oct 24, 2025

Blog

Adoption of the ICH Q12 guideline: New Horizons for Efficient Product Supply Chain Management for a Key Global Market

Nov 13, 2023

Report

New Medicines, Novel Insights: Advancing rare disease drug development

May 22, 2023

Report

New Medicines, Novel Insights: Accelerating development of cell and gene therapies

May 22, 2023

Webinar

Assessing appropriate use of ECAs in clinical trials

May 28, 2023

Blog

Celebrating 40 Years of Rare Disease Progress: WODC Highlights

Jun 6, 2023

Blog

Population variability: important considerations in vaccine development

Jun 14, 2023

Article

The technologies that are reshaping biotherapeutics manufacturing, an EU perspective

Jul 6, 2023

Blog

Ensuring future success in a new market by delivering a robust safety database solution

Aug 4, 2023

Whitepaper

Optimizing the Route to Regulatory Approval for a Novel Vaccine

Aug 18, 2023

Article

Australia: The Regulatory and Reimbursement Environment

Aug 28, 2023

Whitepaper

Scientific Validity Reports: a mandatory requirement for In Vitro Diagnostic Regulation (IVDR)

Sep 19, 2023

Related Insights

Video

Oncology experts roundtable: Practical insights on FDA draft guidance discussing OS data in cancer trials

Oct 24, 2025

Blog

Adoption of the ICH Q12 guideline: New Horizons for Efficient Product Supply Chain Management for a Key Global Market

Nov 13, 2023

Report

New Medicines, Novel Insights: Advancing rare disease drug development

May 22, 2023

Report

New Medicines, Novel Insights: Accelerating development of cell and gene therapies

May 22, 2023

Webinar

Assessing appropriate use of ECAs in clinical trials

May 28, 2023

Blog

Celebrating 40 Years of Rare Disease Progress: WODC Highlights

Jun 6, 2023

Show more